In 2025, Celltrion Pharm conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards.The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.
| Metric (tonnes) | 2025 | 2024 | 2023 | 2022-2019 |
|---|---|---|---|---|
Total Waste Generated | 460a | 483a | 453a | |
Total Waste Recovered | 148a | 145a | 11a | |
Total Hazardous Waste Generated | 131a | 149a | 189a | |
Non-Hazardous Waste Disposed | 289a | 308a | 253a |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.
In 2025, Celltrion Pharm generated a total of 460metric tonnes of waste.a
Of this amount, 32.17% of Celltrion Pharm's total waste generated was recovered through methods such as recycling, reuse, or composting, while 68.04% was disposed of through landfilling, incineration, or combustion.a
In 2025, Celltrion Pharm reported a total waste generation of 460 metric tonnes, of which 32.17% was recovered through recycling, reuse, or composting.This moderate level of recovery indicates that Celltrion Pharm is taking steps toward improving its waste diversion practices, though there is still room to enhance recycling and recovery efforts.a
Since 2022, Celltrion Pharm's total waste generation increased by 5.99%, but declined by 4.76% in the year 2025, suggesting a potential shift toward more efficient material use or the early impact of waste reduction strategies.a
Over the same period, Celltrion Pharm's waste recovery rate increased by 3,390.87%, including a 7.17% rise in 2025, indicating growing emphasis on circularity and improved operational practices for diverting waste from disposal.a
Overall, while Celltrion Pharm has increased waste over the long term, recent reductions in waste generation and strong improvements in recovery indicate a strategic pivot toward better waste management and more sustainable practices.
In 2025, Celltrion Pharm generated a total of 460 metric tonnes of waste.a
Of this amount, 28.48% of Celltrion Pharm's total waste generated of was classified as hazardous waste, characterized by properties such as toxicity, flammability, corrosiveness, or reactivity that may pose risks to human health, ecosystems, or the environment.71.74% was identified as non-hazardous waste, generally considered less harmful and subject to lighter regulatory controls.a
Since 2022, Celltrion Pharm's total waste generation rose by 5.99%, but dropped by 4.76% in 2025, indicating a possible turning point driven by improved waste-reduction practices or production slowdowns.a
Over the same period, Celltrion Pharm reduced the hazardousness of its waste by 40.58%, with a further 7.68% decline in 2025, suggesting a sustained and meaningful shift toward safer waste profiles and lower environmental impact.a
Overall, Celltrion Pharm has increased waste over time but is now demonstrating meaningful progress in both reducing waste generation and lowering its hazardous content, potentially signaling a turning point toward sustainability.a
In 2025, Celltrion Pharm reported that 131 metric tonnes of its total waste output were classified as hazardous. This represents 28.48% of its overall waste generation.a
The company treated this hazardous waste using a combination of methods.A majority (80.92%) was diverted from disposal through recovery-oriented treatments such as recycling or reuse. This suggests that Celltrion Pharm has established processes to reduce the environmental burden of its most harmful waste streams.a